What a pity that a Republican administration needs to be reminded that this misguided policy won’t make America healthy or ...

New research shows the technology’s potential to help find treatments for diseases that have baffled scientists.

In the second part of his Pharma Commerce video interview, Kevin Dondarski, Deloitte’s life sciences R&D strategy leader, ...

President Donald Trump is right that Americans pay too high a price for many pharmaceuticals. In a May 12 speech and signing of an executive order aimed at rectifying the ...

US President Donald Trump’s effort to reduce drug prices for Americans relies on a practice long employed in Europe: aligning ...

BioCardia, Inc. ( NASDAQ: BCDA) Q1 2025 Earnings Conference Call May 14, 2025, 16:30 PM ET Peter Altman - President and CEO David McClung - CFO Miranda Peto - IR Joe Pantginis - H.C. Wainwright Laura ...

Toward the end of his first Administration, Trump signed a similar Executive Order aimed at lowering the prices of some drugs ...

Absci entered its new drug into Phase I trials in half the time and for many millions of dollars less than it would have cost ...

Intrepid Labs, a biotechnology company transforming drug formulation development through the use of artificial intelligence (AI) and robotics, emerged from stealth today to accelerate therapeutics ...

Dimerix and its kidney drug is on track but with results of its phase III trial not due for years, a few more twists and turns are likely.

Makers of organoids and cell models cheered the decision and said it will bolster the development of precision medicines, ...

Istaroxime also has a USPTO issued method of use patent providing protection until 2039 and a pending method of use patent providing protection until 2043. “We believe that the NCE exclusivity ...